{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:58:40Z","timestamp":1784811520101,"version":"3.55.0"},"reference-count":46,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/100011094","name":"Public Health Agency of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011094","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2019,2,5]]},"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>To systematically review screening and treatment effectiveness, and patient preferences, to inform recommendations by the Canadian Task Force on Preventive Health Care on screening for asymptomatic bacteriuria in pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>We searched multiple databases (inception to September 2017) and grey literature sources for studies on screening effectiveness and patient preferences. For treatment with antibiotics, we searched three databases for systematic reviews and obtained search results of the Cochrane Pregnancy and Childbirth Group\u2019s Trials Register to update a Cochrane review. Study selection, risk of bias assessment and evaluation of the quality for each outcome using Grading of Recommendations Assessment, Development and Evaluation was completed independently by two reviewers with consensus. Meta-analysis was conducted when appropriate as were analyses based on planned subgroup variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Outcomes<\/jats:title><jats:p>For screening and treatment effectiveness: maternal and perinatal mortality, maternal and neonatal sepsis, pyelonephritis, spontaneous abortion, preterm delivery, low birth weight and serious adverse events. Valuation of outcomes for patient preferences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Four studies compared outcomes before and after the introduction of a screening programme or between different screening programmes. All evidence on screening effectiveness was considered very low quality. Women have conflicting opinions about antibiotic use during pregnancy. Fifteen trials compared antibiotic treatment with no treatment or placebo in women with confirmed bacteriuria. Low-quality evidence found that treatment lowered rates of pyelonephritis (12 trials, relative risk [RR] 0.24; 95%\u2009CI 0.13 to 0.42; absolute risk reduction [ARR] 17.6%; number needed to treat [NNT] 6, 95%\u2009CI 5 to 7) and low birth weight (seven trials, RR 0.63; 95%\u2009CI 0.45 to 0.90; ARR 4.4%; NNT 23, 95%\u2009CI 15 to 85).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Antibiotic treatment for women having significant bacteriuria likely reduces the incidence of pyelonephritis and low birth weight, but we are uncertain about the magnitude of the effect and about the extent to which we can apply these results to asymptomatic populations and screening programmes.<\/jats:p><\/jats:sec><jats:sec><jats:title>PROSPERO registration number<\/jats:title><jats:p>CRD42016045263.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2017-021347","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T10:05:35Z","timestamp":1552557935000},"page":"e021347","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":42,"title":["Asymptomatic bacteriuria in pregnancy: systematic reviews of screening and treatment effectiveness and patient preferences"],"prefix":"10.1136","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8024-5221","authenticated-orcid":false,"given":"Aireen","family":"Wingert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Sebastianski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9941-9981","authenticated-orcid":false,"given":"Michelle","family":"Gates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Featherstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassi","family":"Shave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Vandermeer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,3,13]]},"reference":[{"key":"2024051712244401000_9.3.e021347.1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ucl.2015.05.004","article-title":"Urinary tract infection and bacteriuria in pregnancy","volume":"42","author":"Glaser","year":"2015","journal-title":"Urol Clin North Am"},{"key":"2024051712244401000_9.3.e021347.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2008.02009.x"},{"key":"2024051712244401000_9.3.e021347.3","doi-asserted-by":"publisher","DOI":"10.1111\/1574-6968.12204"},{"key":"2024051712244401000_9.3.e021347.4","doi-asserted-by":"crossref","unstructured":"Smaill FM , Vazquez JC . Antibiotics for asymptomatic bacteriuria in pregnancy. Cochrane Database Syst Rev 2015:CD000490.doi:10.1002\/14651858.CD000490.pub3","DOI":"10.1002\/14651858.CD000490.pub3"},{"key":"2024051712244401000_9.3.e021347.5","first-page":"CD007855","article-title":"Different antibiotic regimens for treating asymptomatic bacteriuria in pregnancy","volume":"9","author":"Guinto","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"2024051712244401000_9.3.e021347.6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0891-5520(20)30151-3","article-title":"Bacteriuria in pregnancy","volume":"1","author":"Patterson","year":"1987","journal-title":"Infect Dis Clin North Am"},{"key":"2024051712244401000_9.3.e021347.7","unstructured":"Canadian Agency for Drugs and Technologies in Health. Grey matters: a practical tool for searching health-related grey literature. Ottawa, ON, 2015."},{"key":"2024051712244401000_9.3.e021347.8","unstructured":"Evidence Partners Inc. Distiller (DistillerSR systematic review software program). http:\/\/systematic-review.net\/ (cited: 20 Dec 2017)."},{"key":"2024051712244401000_9.3.e021347.9","unstructured":"Centre for Evidence-based Management (CEBMa). Critical appraisal of a cross-sectional study (survey). https:\/\/www.cebma.org\/resources-and-tools\/what-is-critical-appraisal\/ (cited: 28 Jan 2017)."},{"key":"2024051712244401000_9.3.e021347.10","unstructured":"Higgins JP , Green S . Section 8. Assessing risk of bias in included studies. from:http:\/\/handbook.cochrane.org (cited: 20 Dec 2017)."},{"key":"2024051712244401000_9.3.e021347.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.01.012"},{"key":"2024051712244401000_9.3.e021347.12","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629"},{"key":"2024051712244401000_9.3.e021347.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.011"},{"key":"2024051712244401000_9.3.e021347.14","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-6-62"},{"key":"2024051712244401000_9.3.e021347.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2011.01.012"},{"key":"2024051712244401000_9.3.e021347.16","unstructured":"McMaster University. GRADEpro (GRADEpro GDT computer software). https:\/\/gradepro.org (cited: 20 Dec 2017)."},{"key":"2024051712244401000_9.3.e021347.17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.04.026"},{"key":"2024051712244401000_9.3.e021347.18","first-page":"243","article-title":"[Importance of systematic research of urinary infection in pregnant women and the cost of its detection. Proposal for a practical approach]","volume":"12","author":"G\u00e9rard","year":"1983","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"2024051712244401000_9.3.e021347.19","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/169.6.1390"},{"key":"2024051712244401000_9.3.e021347.20","first-page":"214","article-title":"Indicated vs. routine prenatal urine chemical reagent strip testing","volume":"52","author":"Rhode","year":"2007","journal-title":"J Reprod Med"},{"key":"2024051712244401000_9.3.e021347.21","first-page":"281","article-title":"Should asymptomatic bacteriuria be screened in pregnancy?","volume":"29","author":"Uncu","year":"2002","journal-title":"Clin Exp Obstet Gynecol"},{"key":"2024051712244401000_9.3.e021347.22","doi-asserted-by":"publisher","DOI":"10.1016\/S0266-6138(05)80172-X"},{"key":"2024051712244401000_9.3.e021347.23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/S1473-3099(15)00070-5","article-title":"Maternal and neonatal consequences of treated and untreated asymptomatic bacteriuria in pregnancy: a prospective cohort study with an embedded randomised controlled trial","volume":"15","author":"Kazemier","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"2024051712244401000_9.3.e021347.24","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0019-5359.26602","article-title":"Drug utilization pattern during pregnancy in North India","volume":"60","author":"Sharma","year":"2006","journal-title":"Indian J Med Sci"},{"key":"2024051712244401000_9.3.e021347.25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pec.2014.04.014","article-title":"Health literacy and its association with perception of teratogenic risks and health behavior during pregnancy","volume":"96","author":"Lupattelli","year":"2014","journal-title":"Patient Educ Couns"},{"key":"2024051712244401000_9.3.e021347.26","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.healthpol.2008.11.011","article-title":"Study of awareness among pregnant women of the effects of drugs on the fetus and mother in Iran","volume":"91","author":"Mashayekhi","year":"2009","journal-title":"Health Policy"},{"key":"2024051712244401000_9.3.e021347.27","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-009-0744-2"},{"key":"2024051712244401000_9.3.e021347.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-2115(00)00375-4"},{"key":"2024051712244401000_9.3.e021347.29","doi-asserted-by":"publisher","DOI":"10.1007\/s11096-016-0322-5"},{"issue":"Supp 4","key":"2024051712244401000_9.3.e021347.30","first-page":"113","article-title":"The effects of bacteriuria in pregnancy on maternal and fetal health","volume":"4","author":"Brumfitt","year":"1975","journal-title":"Kidney Int Suppl"},{"key":"2024051712244401000_9.3.e021347.31","first-page":"142","article-title":"Use of sulfasymazine in the treatment of bacteriuria of pregnancy","volume":"6","author":"Elder","year":"1966","journal-title":"Antimicrob Agents Chemother"},{"key":"2024051712244401000_9.3.e021347.32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/0002-9378(71)90793-9","article-title":"The natural history of asymptomatic bacteriuria during pregnancy: the effect of tetracycline on the clinical course and the outcome of pregnancy","volume":"111","author":"Elder","year":"1971","journal-title":"Am J Obstet Gynecol"},{"key":"2024051712244401000_9.3.e021347.33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6592.270"},{"key":"2024051712244401000_9.3.e021347.34","first-page":"417","article-title":"Urinary antiseptics in asymptomatic bacteriuria of pregnancy","volume":"81","author":"Furness","year":"1975","journal-title":"N Z Med J"},{"key":"2024051712244401000_9.3.e021347.35","first-page":"206","article-title":"Asymptomatic bacteriuria during pregnancy","volume":"27","author":"Gold","year":"1966","journal-title":"Obstet Gynecol"},{"key":"2024051712244401000_9.3.e021347.36","unstructured":"Kass E . The role of asymptomatic bacteriuria in the pathogenesis of pyelonephritis. In: Quinn EL , Kass EH , eds. Biology of pyelonephritis. Boston: Little Brown and Company, 1960:399\u2013412."},{"key":"2024051712244401000_9.3.e021347.37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(65)90001-2","article-title":"Bacteriuria in pregnancy","volume":"1","author":"Kincaid-Smith","year":"1965","journal-title":"Lancet"},{"key":"2024051712244401000_9.3.e021347.38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0140-6736(66)90534-4","article-title":"The incidence of urinary infection in 5000 pregnant women","volume":"2","author":"Little","year":"1966","journal-title":"Lancet"},{"key":"2024051712244401000_9.3.e021347.39","first-page":"89","article-title":"Bacteriuria in pregnancy","volume":"16","author":"Mulla","year":"1960","journal-title":"Obstet Gynecol"},{"key":"2024051712244401000_9.3.e021347.40","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/120.1.91"},{"key":"2024051712244401000_9.3.e021347.41","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(87)90234-0","article-title":"Antibiotic elimination of group-B streptococci in urine in prevention of preterm labour","volume":"1","author":"Thomsen","year":"1987","journal-title":"Lancet"},{"key":"2024051712244401000_9.3.e021347.42","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.3.5664.212"},{"key":"2024051712244401000_9.3.e021347.43","doi-asserted-by":"crossref","first-page":"596","DOI":"10.5694\/j.1326-5377.1969.tb107290.x","article-title":"Subclinical renal infection and prematurity","volume":"2","author":"Wren","year":"1969","journal-title":"Med J Aust"},{"key":"2024051712244401000_9.3.e021347.44","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12884-016-1128-0","article-title":"Benefits and harms of screening for and treatment of asymptomatic bacteriuria in pregnancy: a systematic review","volume":"16","author":"Angelescu","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"2024051712244401000_9.3.e021347.45","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.02876-13"},{"key":"2024051712244401000_9.3.e021347.46","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.00044-16"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2017-021347","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T21:40:35Z","timestamp":1715982035000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2017-021347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,3,13]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/bmjopen-2017-021347"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2017-021347","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]}}}